BMS boosts cancer trials with Sarah Cannon’s clinical research platform
Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute (SCRI), tapping into the institute’s community-based clinical trial network. BMS will plug its cancer pipeline into…